SCHEMBL5792816

SCHEMBL5792816

CCN1CCCC(CNC(=O)c2cc(-c3ccc(Cl)cc3)ccc2N)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 4/20 0.47
CYP2D6 P10635 3/20 0.46
CACNA1H O95180 1/20 0.46
KCNH2 Q12809 1/20 0.46
DRD2 P14416 4/20 0.44
DRD3 P35462 3/20 0.44
DRD4 P21917 2/20 0.44
KMT2A Q03164 4/20 0.42
POLB P06746 1/20 0.42
MALT1 Q9UDY8 1/20 0.42
HTR2C P28335 1/20 0.42
TP53 P04637 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
MAPK1 P28482 1/20 0.42
CHRNB2 P17787 1/20 0.42
CHRNA4 P43681 1/20 0.42
BCHE P06276 1/20 0.42
ALDH1A1 P00352 1/20 0.42
MEN1 O00255 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5791461 0.85 KMT2A (0.49) CCR2DRD2DRD3DRD4KMT2A
SCHEMBL5792050 0.84 DRD2 (0.50) CCR2DRD2DRD3DRD4KMT2A
SCHEMBL5790711 0.82 ACKR3 (0.54) KMT2AALDH1A1MEN1
Trifluoroacetic Acid SCHEMBL5791504 0.78 SLC2A1 (0.44) CYP2D6CACNA1HKCNH2KMT2ATP53
SCHEMBL5792117 0.74 GABRA5 (0.43) KCNH2
SCHEMBL27684193 0.74 NPC1 (0.57) CCR2KMT2APOLBMEN1
SCHEMBL589624 0.72 CHRM1 (0.54) CCR2POLB
SCHEMBL11532875 0.71 CYP2D6 (0.52) CCR2CYP2D6CACNA1HKCNH2DRD2
SCHEMBL5791107 0.69 KMT2A (0.47) CYP2D6CACNA1HKCNH2KMT2AALDH1A1
SCHEMBL5792775 0.69 DRD2 (0.45) CCR2KCNH2DRD2DRD3DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006012577-A2 QUINAZOLINONE DERIVATIVES USEFUL FOR THE REGULATION OF GLUCOSE HOMEOSTASIS AND FOOD INTAKE BAYER PHARMACEUTICALS CORPORATION (US) 2006-02-02 WO disclosed